Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis.

Mansukhani NA, Peters EB, So MM, Albaghdadi MS, Wang Z, Karver MR, Clemons TD, Laux JP, Tsihlis ND, Stupp SI, Kibbe MR.

Macromol Biosci. 2019 Jun;19(6):e1900066. doi: 10.1002/mabi.201900066. Epub 2019 May 8.

PMID:
31066494
2.

Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery.

Peters EB, Tsihlis ND, Karver MR, Chin SM, Musetti B, Ledford BT, Bahnson EM, Stupp SI, Kibbe MR.

Adv Healthc Mater. 2019 Feb;8(3):e1801545. doi: 10.1002/adhm.201801545. Epub 2019 Jan 8.

3.

Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability.

Moynihan KD, Holden RL, Mehta NK, Wang C, Karver MR, Dinter J, Liang S, Abraham W, Melo MB, Zhang AQ, Li N, Gall SL, Pentelute BL, Irvine DJ.

Cancer Immunol Res. 2018 Sep;6(9):1025-1038. doi: 10.1158/2326-6066.CIR-17-0607. Epub 2018 Jun 18.

4.

Metal-catalyzed one-pot synthesis of tetrazines directly from aliphatic nitriles and hydrazine.

Yang J, Karver MR, Li W, Sahu S, Devaraj NK.

Angew Chem Int Ed Engl. 2012 May 21;51(21):5222-5. doi: 10.1002/anie.201201117. Epub 2012 Apr 18. No abstract available.

5.

Bioorthogonal reaction pairs enable simultaneous, selective, multi-target imaging.

Karver MR, Weissleder R, Hilderbrand SA.

Angew Chem Int Ed Engl. 2012 Jan 23;51(4):920-2. doi: 10.1002/anie.201104389. Epub 2011 Dec 12. No abstract available.

6.

Synthesis and evaluation of a series of 1,2,4,5-tetrazines for bioorthogonal conjugation.

Karver MR, Weissleder R, Hilderbrand SA.

Bioconjug Chem. 2011 Nov 16;22(11):2263-70. doi: 10.1021/bc200295y. Epub 2011 Oct 24.

7.

Targeted nanoagents for the detection of cancers.

McCarthy JR, Bhaumik J, Karver MR, Sibel Erdem S, Weissleder R.

Mol Oncol. 2010 Dec;4(6):511-28. doi: 10.1016/j.molonc.2010.08.003. Epub 2010 Sep 8. Review.

8.

Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.

Karver MR, Krishnamurthy D, Bottini N, Barrios AM.

J Inorg Biochem. 2010 Mar;104(3):268-73. doi: 10.1016/j.jinorgbio.2009.12.012. Epub 2009 Dec 28.

9.

Identifying potent, selective protein tyrosine phosphatase inhibitors from a library of Au(I) complexes.

Karver MR, Krishnamurthy D, Kulkarni RA, Bottini N, Barrios AM.

J Med Chem. 2009 Nov 12;52(21):6912-8. doi: 10.1021/jm901220m.

10.

Identifying and characterizing the biological targets of metallotherapeutics: Two approaches using Au(I)-protein interactions as model systems.

Karver MR, Barrios AM.

Anal Biochem. 2008 Nov 1;382(1):63-5. doi: 10.1016/j.ab.2008.07.019. Epub 2008 Jul 26.

PMID:
18692018
11.

Gold(I)-mediated inhibition of protein tyrosine phosphatases: a detailed in vitro and cellular study.

Krishnamurthy D, Karver MR, Fiorillo E, OrrĂº V, Stanford SM, Bottini N, Barrios AM.

J Med Chem. 2008 Aug 14;51(15):4790-5. doi: 10.1021/jm800101w. Epub 2008 Jul 8.

PMID:
18605719

Supplemental Content

Loading ...
Support Center